Research suggests that KRT17 may play a role in promoting triple negative breast cancer. The mechanism of this promotion is thought to involve the activation of Wnt signaling and the recruitment of γδ T-cells. Other studies have explored various factors and pathways that may contribute to the progression of triple-negative breast cancer and other types of cancer.